GHK-Cu vs minoxidil for hair: the evidence side by side

Reviewed 22 sourcesPublished by PepVault

GHK-Cu vs minoxidil for hair: the trials and FDA labels behind minoxidil, the small studies and lab work behind GHK-Cu, and what oral minoxidil adds.

A man with thick wavy hair in a white t-shirt towel-drying his hair on a balcony
Last reviewed
Sources
22
Questions
10
Compounds
1

The short answer

Minoxidil has the trials. In a 48-week trial of 393 men, 5% minoxidil regrew more hair than 2% or placebo, women's trials found the same, and it is sold over the counter. GHK-Cu has no scalp hair-loss trial of its own and has never been tested against minoxidil in people. Its hair data are one small eyebrow trial, mixtures, cells and rodents.

Every number checked at its primary source · · 22 sources · How we research

Evidence: Minoxidil: large randomized placebo-controlled trials in men and women, and FDA over-the-counter approval. GHK-Cu for hair: one small eyebrow trial, combination products, and cell and rodent studies.

A man with thick wavy hair in a white t-shirt towel-drying his hair on a balcony

Which has more evidence, GHK-Cu or minoxidil?

Minoxidil, by a wide margin. It has placebo-controlled trials with hundreds of men and women, and the FDA lets it be sold without a prescription126. GHK-Cu, a copper peptide used in skin care, has been tested on its own on human hair once: on eyebrows, in 18 people15.

At a glanceMinoxidil on the scalpGHK-Cu on the scalp
What it isA blood-pressure drug that regrows hair on the scalp620Three amino acids holding a copper ion; a cosmetic ingredient
US status for hair lossApproved over the counter: 2% and 5% solution, 5% foam678Not approved for hair loss
Largest hair trial393 men, 48 weeks, against 2% and placebo118 adults, eyebrows only, 12 weeks15
Trials in women381 women for 48 weeks; 404 women for 24 weeks24None on the scalp
Tested against the otherNot in people; once in mice12Not in people; once in mice12
Common side effectsItching, scalp irritation, unwanted facial hair126Few reported; no serious effects in the eyebrow trial15
When results showFrom 2 to 4 months in men, 3 to 6 months in women on the foam, per the labels67No label; the eyebrow trial read its result at 12 weeks15
If you stopHair loss begins again, per the labels67Not studied
Hair studies sized by participants and coloured by subject: minoxidil’s five trials in people (393, 381, 352, 404 and 322); GHK-Cu’s 18-person eyebrow trial, 45 men on a GHK mixture, and studies in mice, rats and a dish
Look at the colour first: almost all of GHK-Cu's hair evidence is below the line where people start.

GHK-Cu for skin, from the wrinkle trials to injection, has its own guide: pepvault.app/guides/ghk-cu-skin-and-hair.

A smiling woman in a blue top leaning on her kitchen counter with her phone and a notebook

PepVault for iPhone

Keep your protocol in PepVault

PepVault's side-effects log keeps each entry with its date, severity and a note, so an itchy week or a shedding phase sits on the calendar beside your start date.

Download on the App Store

7 days free on the yearly plan for new subscribers.

How does each one work on the hair follicle?

A follicle cycles between a growth phase (anagen) and a resting phase (telogen). In pattern hair loss follicles shrink and the growth phase shortens, so hairs come back thinner.

Minoxidil pushes the other way. In animal studies it shortens the resting phase so follicles start growing sooner, and it may lengthen the growth phase and enlarge the follicle; it probably acts the same way in people9. As a tablet it lowers blood pressure by opening potassium channels in blood vessel walls. Whether that channel explains the hair effect had not been shown when that 2004 review was written9.

GHK-Cu is three amino acids, glycine, histidine and lysine, holding one copper ion. Its proposed hair action runs through the dermal papilla, the cells at the base of the follicle that steer its growth: a close relative, AHK-Cu, made those cells multiply and scalp follicles lengthen in a dish10. That is tissue outside the body, not a person's scalp.

The hair cycle as a loop of growth, regression and rest, with a shrunken follicle beside a normal one; minoxidil shortens the rest and lengthens growth in animal data
Minoxidil's effect is on timing and size: follicles start growing sooner and grow larger.
Peptide SkySee GHK-Cu as a molecule53 peptides as a night sky in 3D. Each star opens into its molecule, one bead per amino acid, with the measured shape where one exists.Open the Peptide Sky

What did the minoxidil trials find?

Five randomized trials (pepvault.app/glossary/randomized-controlled-trial) carry most of the weight, counting hairs in a marked patch of scalp against a placebo (pepvault.app/glossary/placebo), the same liquid or foam without minoxidil, or the other strength.

TrialWhoWhat was comparedWhat they found
Olsen 20021393 men aged 18 to 49, 48 weeks5% vs 2% solution vs placebo, twice daily5% beat 2% and placebo; 45% more regrowth than 2% at week 48
Lucky 20042381 women aged 18 to 49, 48 weeks5% vs 2% solution vs placebo, twice dailyBoth strengths beat placebo on hair counts; 5% beat 2% only on the women's own rating of benefit
Olsen 20073352 men aged 18 to 49, 16 weeks5% foam vs placebo foamMore hair on the foam (p < 0.0001)
Bergfeld 20164404 women, 24 weeks5% foam once daily vs placebo foam9.1 more hairs per square centimetre than placebo at week 24
Blume-Peytavi 20165322 women, read at 24 weeks5% foam once daily vs 2% solution twice dailyAbout 24 more hairs per square centimetre than at the start, on each; the test for 'no worse' missed its preset bar

The labels put it plainly. On the men's 5% products, results may show at 2 months or take 4, and they are for the top of the scalp, not a receding hairline6. On the women's once-a-day 5% foam, results may show at 3 months or take 67. The women's 2% label: after 8 months, 19% of women reported moderate regrowth, against 7% on placebo8. Every label says regrowth lasts only with continued use678.

What is the hair evidence for GHK-Cu?

Only the first of these tested GHK-Cu itself on people. Read the third column first.

StudyWhat was testedWho or whatWhat they found
Bo 2026152% GHK-Cu serum on one eyebrow, placebo serum on the other, twice daily18 healthy adults aged 18 to 40, 12 weeksMore and thicker eyebrow hairs on the GHK-Cu side; no serious side effects
Lee 201613GHK joined to 5-aminolevulinic acid, no copper, on the scalp45 men with pattern hair loss, 6 months, vs placeboHair count rose more than on placebo; no difference in thickness or length
Kapoor 201814Scalp injections of six growth factors and peptides, copper tripeptide-1 among them1,000 patients, no control groupLess shedding and more hair; GHK-Cu's share can't be separated
Liu 2023122% GHK-Cu in a microemulsion vs 5% minoxidil vs salineShaved healthy mice, 6 per group, 21 daysThe authors report regrowth beyond minoxidil's
Uno and Kurata 199311PC1031, a synthetic copper-binding peptide, not GHK-CuFuzzy ratsLarger follicles, an effect the authors likened to topical minoxidil's
Pyo 200710AHK-Cu, a related copper tripeptideHuman scalp follicles and papilla cells in a dishFollicles grew longer; papilla cells multiplied

The eyebrow trial is well designed, randomized and double-blind (pepvault.app/glossary/double-blind) with one brow as the other's control, but it had 18 people, appeared in conference proceedings PubMed does not index, and treated brows, not a thinning scalp15. A 2026 systematic review of GHK-Cu on its own in aesthetic medicine found 20 studies, 18 of them preclinical, and only 2 randomized trials, both on skin16. A second 2026 review, of peptide products for hair loss in people, found 14 trials and rated formulas containing GHK, combinations with other peptides among them, at grade B on an A-to-C scale22.

Species note: the Liu, Uno and Pyo results are from mice, rats (pepvault.app/glossary/in-vivo) and human tissue in a dish (pepvault.app/glossary/in-vitro): copper peptides acting on follicles, not a serum regrowing a person's hair.

Has anyone tested GHK-Cu against minoxidil?

Not in people. The one direct comparison is in mice: in shaved mice, 6 per group, a 2% GHK-Cu microemulsion regrew more fur than 5% minoxidil over 21 days, by the authors' account12. Shaved healthy mice are a model of regrowth after shaving, not of pattern hair loss.

A claim circulates online that a 2022 study found a 0.5% GHK-Cu serum raised hair count 22% in 16 weeks and beat 3% minoxidil; other pages cite a 2006 trial and a 2023 trial of 114 people. On November 20, 2026 we searched PubMed and ClinicalTrials.gov for GHK-Cu and copper peptides in hair loss and found none of them. Until a paper can be read, those numbers have no source.

What about oral minoxidil?

Low-dose oral minoxidil is off-label (pepvault.app/glossary/off-label): a doctor prescribes a tablet approved only for severe high blood pressure, at a usual 10 to 40 mg a day, with a boxed warning (pepvault.app/glossary/boxed-warning) written for those patients20. The hair studies use lower amounts: the men's trial below tested 5 mg a day.

The trials so far put it level with topical. In a 24-week randomized trial in 90 men, 5 mg by mouth daily did not beat 5% topical twice daily on hair density17. A 2025 meta-analysis (pepvault.app/glossary/meta-analysis) of four randomized trials and 279 patients found the same hair density and thickness on oral and topical, with extra body and facial hair about twice as common on oral18. In the largest safety study, 1,404 patients, 15.1% had extra hair growth, 1.7% lightheadedness and 1.3% fluid retention; 1.7% stopped over a side effect19.

In 2025, 43 hair-loss dermatologists from 12 countries agreed on who suits it and what to check first21. It is a decision made with a doctor, and no trial has compared it with GHK-Cu.

What side effects does each one have?

On the scalp, minoxidil's usual effects are itching and irritation, a little more often on 5% than on 2%12. In women on 5%, extra hair outside the scalp (hypertrichosis) was more common than on 2% or placebo2. In the eyebrow trial, GHK-Cu caused no serious side effects or allergic reactions, and the 2016 scalp trial of GHK with 5-aminolevulinic acid recorded no adverse events1315.

Commonly reported: a few weeks of extra shedding in the first two months of minoxidil, which users describe as settling; an itchy or flaky scalp on solutions; a faint blue tint and occasional mild tingling from GHK-Cu serums.

When to get help The minoxidil labels say to stop and ask a doctor if chest pain, a racing heartbeat, faintness or dizziness, sudden weight gain, or swollen hands or feet appear67.

Can you use GHK-Cu and minoxidil together?

No trial has tested the pairing. The minoxidil labels say not to use it if you use other medicines on the scalp67; a cosmetic serum isn't a medicine, and a pharmacist can say whether a particular product counts.

How do you tell if it's working?

  1. Before the first use, photograph the top and the parting in the same light and angle, hair dry and combed the same way.
  2. Write down the start date, the product and its strength.
  3. Use it the same way every day; the labels say regrowth only lasts with continued use6.
  4. Compare new photos with the first ones at month 2 and month 4 (month 3 and month 6 on the women's foam), the points the labels name67.
  5. If there is no regrowth by month 4 on the men's products or month 6 on the women's foam, the labels say to stop and ask a doctor67.
A six-month timeline: on the men’s 5% minoxidil label results may show from month 2 and to stop and ask if nothing by month 4; on the women’s 5% foam, month 3 and month 6
Photo days line up with the labels' checkpoints; before them, no change is expected.

PepVault's side-effects log keeps each entry with its date, severity and a note, so an itchy week or a shedding phase sits on the calendar beside your start date. Log it in PepVault

Where to read more

  • The GHK-Cu library page, pepvault.app/peptides/ghk-cu, with its side effects, how long it takes to work and legal status pages.
  • Study pages for GHK-Cu, from pepvault.app/research/ghk-cu-maquart-1993 to pepvault.app/research/ghk-cu-mokhtar-2026.
  • Peptides for skin, side by side: pepvault.app/peptides/for/skin.
  • Next guide: GHK-Cu for skin and hair, what's measured.

Track it in the app

Sources

  1. Olsen EA et al. A randomized clinical trial of 5% topical minoxidil versus 2% topical minoxidil and placebo in the treatment of androgenetic alopecia in men. J Am Acad Dermatol. 2002. PubMed 12196747
  2. Lucky AW et al. A randomized, placebo-controlled trial of 5% and 2% topical minoxidil solutions in the treatment of female pattern hair loss. J Am Acad Dermatol. 2004. PubMed 15034503
  3. Olsen EA et al. A multicenter, randomized, placebo-controlled, double-blind clinical trial of a novel formulation of 5% minoxidil topical foam versus placebo in the treatment of androgenetic alopecia in men. J Am Acad Dermatol. 2007. PubMed 17761356
  4. Bergfeld W et al. A phase III, multicenter, parallel-design clinical trial to compare the efficacy and safety of 5% minoxidil foam versus vehicle in women with female pattern hair loss. J Drugs Dermatol. 2016. PubMed 27391639
  5. Blume-Peytavi U et al. Efficacy and safety of once-daily minoxidil foam 5% versus twice-daily minoxidil solution 2% in female pattern hair loss: a phase III, randomized, investigator-blinded study. J Drugs Dermatol. 2016. PubMed 27391640
  6. DailyMed. Men's Rogaine Extra Strength (minoxidil 5%) topical solution, drug facts label (Kenvue, Nov 2026). dailymed.nlm.nih.gov
  7. DailyMed. Women's Rogaine (minoxidil 5%) topical foam, drug facts label (Nov 2024). dailymed.nlm.nih.gov
  8. DailyMed. Women's Rogaine (minoxidil 2%) topical solution, drug facts label (Sep 2024). dailymed.nlm.nih.gov
  9. Messenger AG, Rundegren J. Minoxidil: mechanisms of action on hair growth. Br J Dermatol. 2004. PubMed 14996087
  10. Pyo HK et al. The effect of tripeptide-copper complex on human hair growth in vitro. Arch Pharm Res. 2007. PubMed 17703734
  11. Uno H, Kurata S. Chemical agents and peptides affect hair growth. J Invest Dermatol. 1993. PubMed 8326148
  12. Liu T et al. Thermodynamically stable ionic liquid microemulsions pioneer pathways for topical delivery and peptide application. Bioact Mater. 2023. PubMed 38026438
  13. Lee WJ et al. Efficacy of a complex of 5-aminolevulinic acid and glycyl-histidyl-lysine peptide on hair growth. Ann Dermatol. 2016. PubMed 27489425
  14. Kapoor R, Shome D. Intradermal injections of a hair growth factor formulation for enhancement of human hair regrowth: safety and efficacy evaluation in a first-in-man pilot clinical study. J Cosmet Laser Ther. 2018. PubMed 29482481
  15. Bo SL et al. The efficacy of 2% copper peptide (GHK-Cu) serum for eyebrow hypotrichosis: a randomized, double-blind, vehicle-controlled, split-face comparative study. Procedia of Multidisciplinary Research. 2026;4(5). so09.tci-thaijo.org
  16. Mokhtar J et al. The regenerative potential of GHK-Cu in aesthetic medicine. Aesthet Surg J. 2026. PubMed 42619529
  17. Penha MA et al. Oral minoxidil vs topical minoxidil for male androgenetic alopecia: a randomized clinical trial. JAMA Dermatol. 2024. PubMed 38598226
  18. Sobral MVS et al. Efficacy and safety of oral minoxidil versus topical solution in androgenetic alopecia: a meta-analysis of randomized clinical trials. Int J Dermatol. 2025. PubMed 39425514
  19. Vañó-Galván S et al. Safety of low-dose oral minoxidil for hair loss: a multicenter study of 1404 patients. J Am Acad Dermatol. 2021. PubMed 33639244
  20. DailyMed. Minoxidil tablets, prescribing information (American Health Packaging, Aug 2026). dailymed.nlm.nih.gov
  21. Akiska YM et al. Low-dose oral minoxidil initiation for patients with hair loss: an international modified Delphi consensus statement. JAMA Dermatol. 2025. PubMed 39565602
  22. Joerg L, Zafar K, Jagdeo J. Peptides for hair growth and treatment of hair loss and alopecia: a systematic review. J Drugs Dermatol. 2026. PubMed 42976838

Newsletter · Weekly

The weekly peptide briefing.

New guides, the week’s peptide news, one tool. Free, one email a week, unsubscribe anytime.

We’ll email you a link to confirm. Your address is used for the briefing only. Privacy

PepVault for iPhone

Keep your protocol in PepVault

Log every dose, track every vial, and see your protocol come together.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Explore the live demo